UBS Group’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.4M | Sell |
|
|||||
|
2025
Q1 | $20.2M | Buy |
|
|||||
|
2024
Q4 | $1.48M | Buy |
|
|||||
|
2024
Q3 | $1.61M | Buy |
|
|||||
|
2024
Q2 | $1.38M | Sell |
|
|||||
|
2024
Q1 | $1.42M | Buy |
|
|||||
|
2023
Q4 | $1.1M | Buy |
|
|||||
|
2023
Q3 | $872K | Sell |
|
|||||
|
2023
Q2 | $980K | Sell |
|
|||||
|
2023
Q1 | $1.09M | Sell |
|
|||||
|
2022
Q4 | $32.1M | Sell |
|
|||||
|
2022
Q3 | $34.3M | Buy |
|
|||||
|
2022
Q2 | $38M | Buy |
|
|||||
|
2022
Q1 | $1.02M | Buy |
|
|||||
|
2021
Q4 | $443K | Sell |
|
|||||
|
2021
Q3 | $548K | Buy |
|
|||||
|
2021
Q2 | $456K | Sell |
|
|||||
|
2021
Q1 | $718K | Buy |
|
|||||
|
2020
Q4 | $421K | Sell |
|
|||||
|
2020
Q3 | $430K | Sell |
|
|||||
|
2020
Q2 | $475K | Sell |
|
|||||
|
2020
Q1 | $611K | Sell |
|
|||||
|
2019
Q4 | $802K | Buy |
|
|||||
|
2019
Q3 | $573K | Sell |
|
|||||
|
2019
Q2 | $693K | Sell |
|
|||||
|
2019
Q1 | $725K | Sell |
|
|||||
|
2018
Q4 | $736K | Sell |
|
|||||
|
2018
Q3 | $1.15M | Buy |
|
|||||
|
2018
Q2 | $993K | Buy |
|
|||||
|
2018
Q1 | $956K | Sell |
|
|||||
|
2017
Q4 | $5.75M | Sell |
|
|||||
|
2017
Q3 | $6.98M | Buy |
|
|||||
|
2017
Q2 | $6.26M | Buy |
|
|||||
|
2017
Q1 | $5.51M | Buy |
|
|||||
|
2016
Q4 | $5.17M | Buy |
|
|||||
|
2016
Q3 | $1.14M | Buy |
|
|||||
|
2016
Q2 | $954K | Sell |
|
|||||
|
2016
Q1 | $1.18M | Buy |
|
|||||
|
2015
Q4 | $1.12M | Sell |
|
|||||
|
2015
Q3 | $1.1M | Sell |
|
|||||
|
2015
Q2 | $1.56M | Buy |
|
|||||
|
2015
Q1 | $1.19M | Sell |
|
|||||
|
2014
Q4 | $1.52M | Buy |
|